| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Aug 3 | MPLAN | 2,500 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Aug 3 | SPLAN | 2,500 | $16.01 | $40K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Aug 3 | MPLAN | 2,500 | $1.01 | $3K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Jul 8 | MPLAN | 2,500 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Jul 8 | SPLAN | 2,500 | $16.00 | $40K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Jul 8 | MPLAN | 2,500 | $1.01 | $3K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Jun 30 | MPLAN | 2,500 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Jun 30 | MPLAN | 7,500 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Jun 30 | SPLAN | 10,000 | $16.01 | $160K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Jun 30 | MPLAN | 2,500 | $1.26 | $3K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Jun 30 | MPLAN | 7,500 | $1.01 | $8K |
| KIORA PHARMACEUTICALS INC | KPRX | Carmine N. StengoneDirDERIV | Jun 10 | A | 25,000 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Feb 25 | MPLAN | 2,700 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Feb 24 | MPLAN | 4,400 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Feb 25 | SPLAN | 2,700 | $16.02 | $43K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Feb 25 | MPLAN | 2,700 | $1.26 | $3K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Feb 24 | SPLAN | 4,400 | $16.02 | $70K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Feb 24 | MPLAN | 4,400 | $1.26 | $6K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Feb 11 | MPLAN | 400 | $0.00 | —? |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Feb 11 | SPLAN | 400 | $16.00 | $6K |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEO | Feb 11 | MPLAN | 400 | $1.26 | $504 |
| Contineum Therapeutics, Inc. | CTNM | Carmine N. StengoneCEODERIV | Jan 30 | A | 445,000 | $0.00 | —? |